|
Molecular Targeted Photoimmunotherapy for Bladder Cancer
|
ZIA BC 011458
|
$195,289
|
$195,289
|
Agarwal, Piyush
|
CCR (NCI)
|
|
A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillu
|
ZIA BC 011528
|
$97,645
|
$97,645
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Evaluation of Protein Kinase D1 in Bladder Cancer as a possible oncogene
|
ZIA BC 011592
|
$130,193
|
$130,193
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Investigation of Epigenetic Modifiers in Bladder Cancer
|
ZIA BC 011593
|
$32,548
|
$32,548
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Targeting Metabolic Pathways in Bladder Cancer
|
ZIA BC 011741
|
$130,193
|
$130,193
|
Agarwal, Piyush
|
CCR (NCI)
|
|
A Phase I Combination Study of Durvalumab and Vicinium in BCG refractory NMIBC
|
ZIA BC 011786
|
$32,548
|
$32,548
|
Agarwal, Piyush
|
CCR (NCI)
|
|
High Throughput Screening of Agents in Bladder Cancer Cell Lines
|
ZIC BC 011531
|
$32,548
|
$32,548
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$755,842
|
$37,792
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Bladder Cancer Program
|
ZIA BC 011351
|
$357,695
|
$357,695
|
Apolo, Andrea
|
CCR (NCI)
|
|
Targeting the MET pathway in urothelial carcinoma
|
ZIA BC 011594
|
$536,543
|
$536,543
|
Apolo, Andrea
|
CCR (NCI)
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$339,315
|
$339,315
|
Barchi, Joseph
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
$76,612
|
Barr, Frederic
|
CCR (NCI)
|
|
Pediatric CT pooling projcect
|
ZIA CP010222-10662
|
$12,669
|
$2,534
|
Berrington, Amy
|
DCEG (NCI)
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$312,747
|
$93,824
|
Beutler, John
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,201,344
|
$630,202
|
Bilusic, Marijo
|
CCR (NCI)
|
|
Hypoxia and Tyrosine Kinase Signaling Integration in Urologic Cancers
|
ZIA BC 011095
|
$191,882
|
$191,882
|
Bottaro, Donald
|
CCR (NCI)
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$356,352
|
$178,176
|
Bottaro, Donald
|
CCR (NCI)
|
|
Molecular biology of human polyomaviruses
|
ZIA BC 011090
|
$362,249
|
$181,125
|
Buck, Christopher
|
CCR (NCI)
|
|
BKV and JCV vaccine development
|
ZIA BC 011460
|
$362,249
|
$253,575
|
Buck, Christopher
|
CCR (NCI)
|
|
Stable Water Isotope Labeling for Imaging of Rapidly Proliferating Cells
|
ZIA BC 011777
|
$24,641
|
$4,928
|
Buxbaum, Nataliya
|
CCR (NCI)
|
|
Families at high risk of cancer
|
ZIA CP004410-08285
|
$246,303
|
$24,630
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Histology Core Laboratory
|
ZIC BC 010687
|
$1,344,149
|
$67,207
|
Chinquee, Joseph
|
CCR (NCI)
|
|
Targeting mechanisms of radiation resistance
|
ZIA BC 011552
|
$471,373
|
$235,687
|
Citrin, Deborah
|
CCR (NCI)
|
|
Screening to identify protectors and mitigators of Radiation GI Syndrome
|
ZIA BC 011762
|
$471,373
|
$188,549
|
Citrin, Deborah
|
CCR (NCI)
|
|
CCR Genomics Core
|
ZIC BC 011623
|
$850,744
|
$85,074
|
Conner, Elizabeth
|
CCR (NCI)
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,497,944
|
$724,898
|
Custer, Mary
|
CCR (NCI)
|
|
Molecular Modeling of the Human P-glycoprotein Transporter Protein
|
ZIC BC 011075
|
$58,595
|
$29,297
|
Durell, Stewart
|
CCR (NCI)
|
|
Molecular Profiling of Clinical Specimens
|
ZIC BC 011040
|
$2,317,028
|
$463,406
|
Edelman, Daniel
|
CCR (NCI)
|
|
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents
|
ZIC BC 010548
|
$492,058
|
$49,206
|
Figg, William
|
CCR (NCI)
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$272,402
|
$54,480
|
Fowler, Daniel
|
CCR (NCI)
|
|
ZW800-1: The 1st Zwitterionic NIR Fluorophore for Cancer Imaging & Ureter Mapping
|
1R44CA210820-01A1
|
$989,401
|
$989,401
|
FRANGIONI, JOHN
|
CURADEL, LLC
|
|
CCR Confocal Microscopy Core
|
ZIC BC 010858
|
$498,365
|
$49,836
|
Garfield, Susan
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$587,732
|
$35,264
|
Gottesman, Michael
|
CCR (NCI)
|
|
Mechanisms of non-classical multidrug resistance in cancer
|
ZIA BC 010830
|
$1,007,541
|
$50,377
|
Gottesman, Michael
|
CCR (NCI)
|
|
Experimental Pathology Laboratory (EPL)
|
ZIC BC 011638
|
$1,402,891
|
$140,289
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging
|
ZIA BC 010738
|
$905,521
|
$362,209
|
Hou, Steven
|
CCR (NCI)
|
|
Characterization of Biological Nanoparticle Subsets
|
ZIA BC 011502
|
$248,748
|
$12,437
|
Jones, Jennifer
|
CCR (NCI)
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$474,811
|
$9,496
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$511,155
|
$25,558
|
Khan, Javed
|
CCR (NCI)
|
|
The Role of Fgf Signaling in Vertebrate Development
|
ZIA BC 010338
|
$384,245
|
$76,849
|
Lewandoski, Mark
|
CCR (NCI)
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$511,064
|
$383,298
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$1,022,127
|
$766,596
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene
|
ZIA BC 011043
|
$1,022,127
|
$1,011,906
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Clinical Nursing and Data Management Core
|
ZID BC 011089
|
$766,596
|
$498,287
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Urologic Oncology Branch Consult Core
|
ZID BC 011092
|
$1,788,723
|
$1,430,978
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Role of Shh in developmental patterning and growth of digit skeleton
|
ZIA BC 011118
|
$305,052
|
$30,505
|
Mackem, Susan
|
CCR (NCI)
|
|
Defining and Manipulating Epigenomic Regulators in Endogenous Systems
|
ZIA BC 011488
|
$897,044
|
$179,409
|
Meier, Jordan
|
CCR (NCI)
|
|
Study of Hereditary Renal and Other Familial Syndromes
|
ZIA BC 010696
|
$256,176
|
$153,706
|
Merino, Maria
|
CCR (NCI)
|
|
microRNA Profiling in the Spectrum of Kidney Tumors
|
ZIA BC 011405
|
$128,088
|
$128,088
|
Merino, Maria
|
CCR (NCI)
|
|
Translational Surgical Pathology
|
ZIE SC 000853
|
$192,132
|
$90,302
|
Merino, Maria
|
CCR (NCI)
|
Total relevant funding to Urinary System for this search: $17,681,275
|